|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
Valuation Estimation |
EPS (Current/Estimated)
-0.66/--
|
Enterprise Value
19.99M
|
Balance Sheet |
Book Value Per Share
0.14
|
Cash Flow |
Cash Flow Yield
--
|
Income Statement |
Total Revenue
17.07K
|
Operating Revenue Per Share
0.00
|
Industry Comparison
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
Quotes are at least 15-min delayed:2024/05/14 20:30 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
|
|||
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease. |